China News Weekly 119 – London Metal Exchange adds Huayou’s cobalt to its approved list

Suggested Opportunity

RepliCel Life Sciences Inc (TSXV:RP)

RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.

This is NAI’s new China News Weekly. We will be covering the latest Chinese foreign investment trends every week. To continue to receive our China News Weekly, please click the button below to subscribe.

Subscribe for China News Weekly

Cobalt Copper Life Science Medical Device Oil & Gas Pharmaceutical Precious Metals Technology

China News Weekly 119 – London Metal Exchange adds Huayou’s cobalt to its approved list

Suggested Opportunity

RepliCel Life Sciences Inc (TSXV:RP)

Related Posts

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines

TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity

Restaurant Order Automation Drives High Growth: Can SoundHound AI Return to Its Peak?

South American Four-Nation Mineral Agreement Aims at Global Critical Resource Supply Chains

Weekly Market Recap (September 5) – Copper Set for Tenth Consecutive Weekly Gain

Strong Employment Persists While Inflation Remains Stubborn, September Rate Hike Odds Climb